Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangzhou Institute of Biomedicine and Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9296
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that develops protocols for disease control and prevention. The institute conducts research in the areas of stem cell and regenerative medicine, chemical biology, immunology and infectious diseases, public health, and scientific research equipment development. Its life process and disease mechanism provide solutions to the innovation and integration of human health and disease prevention, constructing research and development base for China’s bio-medicine and health and serving national strategic demands and economic and social development. GIBH offers technical services and expertise to local universities and companies in Southern China. It provides mechanisms for controlling the transformation of adult cells into pluripotent stem cells and optimization of protocols for directed differentiation of normal and diseased human iPSCs into different cell lineages. GIBH is headquartered in Guangzhou, China.

Guangzhou Institute of Biomedicine and Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Euclises Pharma Enters into Co-Development Agreement with Guangzhou Institutes of Biomedicine 10
Casigen Pharma Enters Into Co-Development Agreement With Guangzhou Institute of Biomedicine and Health 11
Ventac Partners Enters Into Joint Venture Agreement With Guangzhou Institutes of Biomedicine 12
Guangzhou Institute of Biomedicine and Health – Key Competitors 13
Guangzhou Institute of Biomedicine and Health – Key Employees 14
Guangzhou Institute of Biomedicine and Health – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Government and Public Interest 16
May 24, 2018: Scientists in China and UK work to help tackle global health epidemics 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Key Facts 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Institute of Biomedicine and Health, Deals By Therapy Area, 2012 to YTD 2018 8
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Euclises Pharma Enters into Co-Development Agreement with Guangzhou Institutes of Biomedicine 10
Casigen Pharma Enters Into Co-Development Agreement With Guangzhou Institute of Biomedicine and Health 11
Ventac Partners Enters Into Joint Venture Agreement With Guangzhou Institutes of Biomedicine 12
Guangzhou Institute of Biomedicine and Health, Key Competitors 13
Guangzhou Institute of Biomedicine and Health, Key Employees 14
Guangzhou Institute of Biomedicine and Health, Joint Venture 15

List of Figures
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qiagen Aarhus AS:企業の戦略的SWOT分析
    Qiagen Aarhus AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Chang Chun Petrochemical Co Ltd:企業の戦略的SWOT分析
    Chang Chun Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • ProMIS Neurosciences Inc (PMN):製薬・医療:M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • Lung Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Therapeutics Inc (Lung Therapeutics) is a pharmaceutical company that offers orphan drug indications for lung injury and disease. The company provides service to underserved, life-threatening lung condition pursues an innovative treatment. Its pipeline candidates include LTI-01, single …
  • West Japan Railway Company:企業の戦略・SWOT・財務情報
    West Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary West Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Agilent Technologies, Inc.:戦略・SWOT・企業財務分析
    Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Continental AG:企業のM&A・事業提携・投資動向
    Continental AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Continental AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Oriental Land Co., Ltd. (4661):企業の財務・戦略的SWOT分析
    Oriental Land Co., Ltd. (4661) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • QuikTrip Corporation:企業の戦略的SWOT分析
    QuikTrip Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Visioneering Technologies Inc (VTI):企業の製品パイプライン分析2018
    Summary Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. The company develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel ma …
  • Vesuvius Plc:企業の戦略・SWOT・財務情報
    Vesuvius Plc - Strategy, SWOT and Corporate Finance Report Summary Vesuvius Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • DaVita Inc.:企業のM&A・事業提携・投資動向
    DaVita Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DaVita Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sartorius Stedim Biotech SA (DIM)-医療機器分野:企業M&A・提携分析
    Summary Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to the biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification and lab technologies. Its major products include laboratory balances, OEM weigh cells …
  • Dusit Thani Public Company Limited:戦略・SWOT・企業財務分析
    Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析
    Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Michael J Fox Foundation for Parkinson’s Research-医療機器分野:企業M&A・提携分析
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's diseas …
  • Spectra Energy Partners, LP (SEP)-石油・ガス分野:企業M&A・提携分析
    Summary Spectra Energy Partners, LP (Spectra Energy), a subsidiary of Enbridge Inc., is master limited partnership operating in mid-stream energy. The company conducts transmission, storage and gathering of natural gas. It also carries out the transportation and storage of crude oil, and the transpo …
  • Ig Group Holdings Plc
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆